Hongjing Wang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 7
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 10
- Endometriosis Research and Treatment 7
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 9
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 5
- Pharmacology top 10%
-
- Cervical Cancer and HPV Research 5
- Co-authors
- Kaiping WangYu ZhangLingyun YangZheng CuiNingwei LiTao ZhouFang ChengTao Yi
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongjing Wang
76 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 357
- Reproductive Medicine 113
- Obstetrics and Gynecology 84
- Molecular Biology 678
- Pharmacology 164
Countries citing papers authored by Hongjing Wang
This map shows the geographic impact of Hongjing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjing Wang more than expected).
Fields of papers citing papers by Hongjing Wang
This network shows the impact of papers produced by Hongjing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjing Wang. The network helps show where Hongjing Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongjing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 11 | |
| 16 | 2019 | 28 | |
| 17 | 2018 | 89 | |
| 18 | 2016 | 165 | |
| 19 | 2015 | 48 | |
| 20 | 2012 | 108 |
About Hongjing Wang
Hongjing Wang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 86 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (10 papers), Endometrial and Cervical Cancer Treatments (9 papers), MicroRNA in disease regulation (7 papers), Endometriosis Research and Treatment (7 papers), Cervical Cancer and HPV Research (5 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (357 citations), Reproductive Medicine (113 citations) and Obstetrics and Gynecology (84 citations). Hongjing Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kaiping Wang, Yu Zhang, Lingyun Yang, Zheng Cui, Ningwei Li, Tao Zhou, Fang Cheng, Tao Yi, Ziming Zheng and Mingrong Xi. Their work appears in journals such as ACS Nano, PLoS ONE and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.